| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 10/04/2023 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 370.3k | $0.24 | $88.9k | | 10/04/2023 |
| 06/30/2023 | Krystal Biotech, Inc. | KRYS | Grant | Stock Option (Right to Buy) | 6.8k | $117.40 | $798.3k | | 06/30/2023 |
| 05/03/2023 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 3.5k | $0.00 | $0 | | 05/03/2023 |
| 05/03/2023 | Revance Therapeutics, Inc. | RVNC | Grant | Stock Option (Right to buy) | 5.9k | $33.61 | $198.8k | | 05/03/2023 |
| 03/29/2023 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 41.1k | $1.05 | $43.1k | | 03/29/2023 |
| 10/05/2022 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 74.4k | $1.25 | $93k | | 10/05/2022 |
| 06/30/2022 | Krystal Biotech, Inc. | KRYS | Grant | Stock Option (Right to Buy) | 6.8k | $65.66 | $446.5k | | 06/30/2022 |
| 05/04/2022 | Revance Therapeutics, Inc. | RVNC | Grant | Stock Option (Right to buy) | 10.8k | $18.12 | $194.9k | | 05/04/2022 |
| 05/04/2022 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 6.1k | $0.00 | $0 | | 05/04/2022 |
| 05/04/2022 | Revance Therapeutics, Inc. | RVNC | Grant | Stock Option (Right to buy) | 11.3k | $18.12 | $205.5k | | 05/04/2022 |
| 03/23/2022 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 21.9k | $1.92 | $42k | | 03/23/2022 |
| 10/05/2021 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 44.5k | $2.12 | $94.3k | | 10/05/2021 |
| 06/30/2021 | Krystal Biotech, Inc. | KRYS | Grant | Stock Option (Right to Buy) | 6.8k | $68.00 | $462.4k | | 06/30/2021 |
| 05/05/2021 | Revance Therapeutics, Inc. | RVNC | Grant | Stock Option (Right to buy) | 7.6k | $27.91 | $210.7k | | 05/05/2021 |
| 05/05/2021 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 4k | $0.00 | $0 | | 05/05/2021 |
| 03/24/2021 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 20.9k | $2.27 | $47.4k | | 03/24/2021 |
| 10/05/2020 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 150.7k | $0.71 | $106.3k | | 10/05/2020 |
| 07/17/2020 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 125k | $1.58 | $197.5k | | 07/17/2020 |
| 07/01/2020 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 35k | $1.28 | $44.8k | | 07/01/2020 |
| 06/30/2020 | Krystal Biotech, Inc. | KRYS | Grant | Stock Option (Right to Buy) | 6.8k | $41.42 | $281.7k | | 06/30/2020 |
| 05/14/2020 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 6k | $0.00 | $0 | | 05/14/2020 |
| 05/14/2020 | Revance Therapeutics, Inc. | RVNC | Grant | Stock Option (Right to buy) | 12k | $19.40 | $232.8k | | 05/14/2020 |
| 04/20/2020 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 25k | $0.72 | $18k | | 04/20/2020 |
| 05/10/2019 | GW PHARMACEUTICALS PLC | GWPH | Exercise | Ordinary Shares | 403.8k | $0.00 | $524.9 | | 05/10/2019 |
| 05/10/2019 | GW PHARMACEUTICALS PLC | GWPH | Exercise | Ordinary Shares | 75.4k | $10.61 | $799.7k | | 05/10/2019 |
| 05/10/2019 | GW PHARMACEUTICALS PLC | GWPH | Exercise | Ordinary Shares | 192.8k | $3.72 | $717k | | 05/10/2019 |
| 05/10/2019 | GW PHARMACEUTICALS PLC | GWPH | Sale | Ordinary Shares | 117.9k | $14.63 | $1.7M | | 05/10/2019 |
| 05/10/2019 | GW PHARMACEUTICALS PLC | GWPH | Sale | Ordinary Shares | 81.2k | $14.70 | $1.2M | | 05/10/2019 |
| 05/10/2019 | GW PHARMACEUTICALS PLC | GWPH | Sale | Ordinary Shares | 65.3k | $14.80 | $966k | | 05/10/2019 |
| 05/10/2019 | GW PHARMACEUTICALS PLC | GWPH | Sale | Ordinary Shares | 208.3k | $14.88 | $3.1M | | 05/10/2019 |
| 05/10/2019 | GW PHARMACEUTICALS PLC | GWPH | Sale | Ordinary Shares | 145.2k | $14.96 | $2.2M | | 05/10/2019 |
| 05/10/2019 | GW PHARMACEUTICALS PLC | GWPH | Sale | Ordinary Shares | 12k | $15.03 | $181.1k | | 05/10/2019 |
| 05/10/2019 | GW PHARMACEUTICALS PLC | GWPH | Sale | Ordinary Shares | 31.4k | $15.12 | $474.3k | | 05/10/2019 |
| 05/10/2019 | GW PHARMACEUTICALS PLC | GWPH | Sale | Ordinary Shares | 10.8k | $15.19 | $163.9k | | 05/10/2019 |
| 05/10/2019 | GW PHARMACEUTICALS PLC | GWPH | Exercise | Stock Options | 27.4k | $0.00 | $0 | | 05/10/2019 |
|